About RPM

From Windhover Information, the leading provider of health care business strategy for the biopharma industry.

Welcome to TheRPMReport.com!

The RPM Report is a unique, actionable information resource for biopharmaceutical executives on FDA, CMS and public sector issues. The analysis in The RPM Report is easy to read and easy to use. It is designed to help executives build a comprehensive business strategy around the complicated world of regulation and control of access to drug and biologic products.

Numerous publications report on the FDA and CMS. But only The RPM Report includes detailed, authoritative analysis that tells you exactly what this news means to your company. I encourage you to browse this site to see for yourself how The RPM Report helps you:

• Discover profitable reimbursement strategies
• Turn bad regulatory news into business opportunities
• Uncover new marketing strategies inside regulatory restrictions
• Spot pricing trends before it's too late
• Navigate managed markets with ease
• Protect your market share

For instance, take a look at the Table of Contents for the Current Issue. I guarantee you'll discover business-critical topics that you won't find in any other publication. And if you decide you want to profit from our expert analysis, a subscriber's privileges are only a click away!

In the meantime, thank you for visiting TheRPMReport.com!

Sincerely,
Cole Werble
Editor-in-Chief
The RPM Report